Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
UiPath price target lowered to $72 from $80 at Cowen » 08:11
10/08/21
10/08
08:11
10/08/21
08:11
PATH

UiPath

/

+

Cowen analyst Bryan…

Cowen analyst Bryan Bergin lowered the firm's price target on UiPath to $72 from $80 and keeps an Outperform rating on the shares. The analyst views the recent pullback in the stock as an opportunity to add or initiate positions and notes its price target still suggests a premium valuation. He said the company's competitive position, and new product and channel investments support greater RPA scalability, ease of use, speed to production, and robot resiliency & security; all of which support greater revenue growth potential.

ShowHide Related Items >><<
PATH UiPath
/

+

PATH UiPath
/

+

10/07/21 RBC Capital
UiPath price target lowered to $65 from $74 at RBC Capital
09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
PATH UiPath
/

+

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
/

+

PATH UiPath
/

+

Recommendations
UiPath price target lowered to $65 from $74 at RBC Capital » 06:36
10/07/21
10/07
06:36
10/07/21
06:36
PATH

UiPath

$51.34 /

-0.01 (-0.02%)

RBC Capital analyst…

RBC Capital analyst Matthew Hedberg lowered the firm's price target on UiPath to $65 from $74 and keeps a Sector Perform rating on the shares. The analyst cites the company's user conference presentation, which left him "feeling good" about its opportunity to expand its share in the $60B enterprise automation market. Hedberg adds that the need for automation is significant as customers leverage UiPath's software robots to automate work by emulating human behavior, but his rating and reduced price target are being driven by "peer-group multiple contraction".

ShowHide Related Items >><<
PATH UiPath
$51.34 /

-0.01 (-0.02%)

PATH UiPath
$51.34 /

-0.01 (-0.02%)

09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
09/08/21 Canaccord
UiPath price target lowered to $65 from $75 at Canaccord
PATH UiPath
$51.34 /

-0.01 (-0.02%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
$51.34 /

-0.01 (-0.02%)

PATH UiPath
$51.34 /

-0.01 (-0.02%)

Hot Stocks
ARK Investment bought 580.6K shares of UiPath on Wednesday  19:37
10/06/21
10/06
19:37
10/06/21
19:37
PATH

UiPath

$51.34 /

-0.01 (-0.02%)

 
ShowHide Related Items >><<
PATH UiPath
$51.34 /

-0.01 (-0.02%)

PATH UiPath
$51.34 /

-0.01 (-0.02%)

09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
09/08/21 Canaccord
UiPath price target lowered to $65 from $75 at Canaccord
PATH UiPath
$51.34 /

-0.01 (-0.02%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
$51.34 /

-0.01 (-0.02%)

PATH UiPath
$51.34 /

-0.01 (-0.02%)

Hot Stocks
Crowdstrike, UiPath team 'on new level of security protection' » 08:48
10/05/21
10/05
08:48
10/05/21
08:48
CRWD

Crowdstrike

$238.87 /

-10.365 (-4.16%)

, PATH

UiPath

$51.37 /

-0.795 (-1.52%)

UiPath (PATH), an …

UiPath (PATH), an enterprise automation software company, and CrowdStrike (CRWD), a company that provides endpoint and workload protection announced that the companies have partnered "to deliver a new level of security protection and visibility with the UiPath Robotic Process Automation, RPA, platform and the UiPath . "Together, CrowdStrike and UiPath automatically detect threat activity, whether initiated by humans or robots, to grant the security team real-time visibility across the environment and enable proactive responses," the companies announced.The ability to quickly and easily distinguish between an RPA-initiated process and a human-initiated process will provide security teams with real-time visibility across the environment for proactive threat hunting, incident investigation and remediation. "CrowdStrike and UiPath together bring unparalleled capabilities to the market to mitigate potential risk and increase the visibility of the security organization into robot-led activities," said Amol Kulkarni, CrowdStrike chief product officer. As automation becomes a core part of the enterprise technology stack and protecting against threats becomes more complex, strengthening our joint customers' security posture will positively impact their business outcomes, said the companies in a statement" "RPA is extending further across the enterprise to automate more processes, making it a fundamental operational asset that companies must protect," said Ted Kummert, executive vice president of products and engineering at UiPath. "The challenge of keeping companies, customers and employees safe increases every day. By partnering with CrowdStrike's leading cloud-based security technology, our customers gain the unique advantage of a highly secure and easy to implement end-to-end automation platform."

ShowHide Related Items >><<
PATH UiPath
$51.37 /

-0.795 (-1.52%)

CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 Goldman Sachs
Crowdstrike downgraded to Neutral from Buy at Goldman Sachs
09/09/21 Wells Fargo
SentinelOne price target raised to $80 from $55 at Wells Fargo
09/01/21 BTIG
Crowdstrike price target raised to $313 from $302 at BTIG
PATH UiPath
$51.37 /

-0.795 (-1.52%)

09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
09/08/21 Canaccord
UiPath price target lowered to $65 from $75 at Canaccord
PATH UiPath
$51.37 /

-0.795 (-1.52%)

CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

PATH UiPath
$51.37 /

-0.795 (-1.52%)

CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

PATH UiPath
$51.37 /

-0.795 (-1.52%)

CRWD Crowdstrike
$238.87 /

-10.365 (-4.16%)

Recommendations
GoodRx price target raised to $47 from $37 at Deutsche Bank » 06:45
10/01/21
10/01
06:45
10/01/21
06:45
GDRX

GoodRx

$41.00 /

+0.085 (+0.21%)

Deutsche Bank analyst…

Deutsche Bank analyst Lloyd Walmsley raised the firm's price target on GoodRx to $47 from $37 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

09/14/21 Credit Suisse
GoodRx price target raised to $52 from $45 at Credit Suisse
08/31/21 Barclays
GoodRx upgraded to Overweight from Equal Weight at Barclays
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

GDRX GoodRx
$41.00 /

+0.085 (+0.21%)

Conference/Events
GoodRx to hold an educational webinar » 14:25
09/30/21
09/30
14:25
09/30/21
14:25
GDRX

GoodRx

$41.13 /

+0.215 (+0.53%)

Management holds a…

Management holds a webinar entitled, "101 Educational Webinar" on September 30 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

09/14/21 Credit Suisse
GoodRx price target raised to $52 from $45 at Credit Suisse
08/31/21 Barclays
GoodRx upgraded to Overweight from Equal Weight at Barclays
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

GDRX GoodRx
$41.13 /

+0.215 (+0.53%)

Hot Stocks
SentinelOne, Blackpanda and Pandamatics team on incidence response for APAC » 08:24
09/30/21
09/30
08:24
09/30/21
08:24
S

SentinelOne

$54.57 /

-1.04 (-1.87%)

SentinelOn announced a…

SentinelOn announced a strategic partnership with Blackpanda, Asia's premier digital forensics and incident response firm, and Pandamatics Underwriting, an Asia-focused cyber insurance coverholder. The partnership delivers a single source cyber resilience solution, providing customers with protection against advanced threats. "We've brought a comprehensive cyber resilience offering to market with the goal of providing Asian businesses with complete protection against sophisticated threats," said Gene Yu, CEO, Blackpanda. "The best way to provide incident response services following a breach is to deploy EDR technology that delivers autonomous detection and response capabilities. SentinelOne provides us with this, even as the attack surface has significantly expanded with the shift to work from home and cloud environments." "Blackpanda's unique offering in conjunction with SentinelOne detects threats early to mitigate risk," said Barnaby Page, Senior Director of Business Development, SentinelOne. "Deploying SentinelOne has proven to be an essential first step in incident response cases. The level of autonomy that our Storyline Active Response technology provides accelerates detection time and delivers unrivaled breach recovery."

ShowHide Related Items >><<
S SentinelOne
$54.57 /

-1.04 (-1.87%)

S SentinelOne
$54.57 /

-1.04 (-1.87%)

09/09/21 Needham
SentinelOne price target raised to $82 from $58 at Needham
09/09/21 Loop Capital
SentinelOne price target raised to $82 from $60 at Loop Capital
09/09/21 Jefferies
SentinelOne price target raised to $70 from $65 at Jefferies
09/09/21 Morgan Stanley
SentinelOne price target raised to $70 from $56 at Morgan Stanley
S SentinelOne
$54.57 /

-1.04 (-1.87%)

  • 30
    Jun
S SentinelOne
$54.57 /

-1.04 (-1.87%)

S SentinelOne
$54.57 /

-1.04 (-1.87%)

S SentinelOne
$54.57 /

-1.04 (-1.87%)

Hot Stocks
SL Green Realty signs new lease with UiPath » 07:39
09/30/21
09/30
07:39
09/30/21
07:39
SLG

SL Green Realty

$71.98 /

-1.0317 (-1.41%)

, PATH

UiPath

$52.00 /

-0.36 (-0.69%)

SL Green Realty (SLG)…

SL Green Realty (SLG) announced that global enterprise automation software company, UiPath (PATH), has signed a 15-year, 26,363-square-foot lease at One Vanderbilt Avenue covering the entire 60th floor. The skyline-defining tower in the heart of East Midtown is now over 91% leased. Standing 1,401 feet tall, One Vanderbilt is the new headquarters for many of finance, technology, law and real estate firms.

ShowHide Related Items >><<
SLG SL Green Realty
$71.98 /

-1.0317 (-1.41%)

PATH UiPath
$52.00 /

-0.36 (-0.69%)

SLG SL Green Realty
$71.98 /

-1.0317 (-1.41%)

09/24/21 BofA
SL Green Realty upgraded to Neutral from Underperform at BofA
09/24/21 BofA
SL Green Realty upgraded to Neutral from Underperform at BofA
09/01/21 Barclays
SL Green Realty initiated with an Overweight at Barclays
06/25/21 Deutsche Bank
SL Green Realty price target raised to $77 from $66 at Deutsche Bank
PATH UiPath
$52.00 /

-0.36 (-0.69%)

09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
09/08/21 Canaccord
UiPath price target lowered to $65 from $75 at Canaccord
SLG SL Green Realty
$71.98 /

-1.0317 (-1.41%)

PATH UiPath
$52.00 /

-0.36 (-0.69%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
$52.00 /

-0.36 (-0.69%)

PATH UiPath
$52.00 /

-0.36 (-0.69%)

Conference/Events
GoodRx to hold an educational webinar » 04:55
09/30/21
09/30
04:55
09/30/21
04:55
GDRX

GoodRx

$40.94 /

+0.845 (+2.11%)

Management holds a…

Management holds a webinar entitled, "101 Educational Webinar" on September 30 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

09/14/21 Credit Suisse
GoodRx price target raised to $52 from $45 at Credit Suisse
08/31/21 Barclays
GoodRx upgraded to Overweight from Equal Weight at Barclays
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

GDRX GoodRx
$40.94 /

+0.845 (+2.11%)

Hot Stocks
Alteryx and UiPath expand strategic partnership » 08:09
09/28/21
09/28
08:09
09/28/21
08:09
AYX

Alteryx

$75.41 /

-0.07 (-0.09%)

, PATH

UiPath

$54.45 /

+1.755 (+3.33%)

Alteryx (AYX) and UiPath…

Alteryx (AYX) and UiPath (PATH) announced the expansion of their strategic partnership and new integrations with a connector as part of Alteryx's recent product release. Alteryx will also participate in an expert panel at the UiPath FORWARD IV conference, taking place October 5-6 in Las Vegas, where the company will be exhibiting its Analytic Process Automation, or APA, Platform and bi-directional integration with UiPath.

ShowHide Related Items >><<
PATH UiPath
$54.45 /

+1.755 (+3.33%)

AYX Alteryx
$75.41 /

-0.07 (-0.09%)

AYX Alteryx
$75.41 /

-0.07 (-0.09%)

08/04/21 Cowen
Alteryx price target lowered to $100 from $120 at Cowen
08/04/21 Citi
Alteryx price target lowered to $125 from $136 at Citi
07/12/21 Citi
Broadcom deal for SAS would be positive for Alteryx, says Citi
07/12/21 Rosenblatt
SAS Institute competes directly with Alteryx, says Rosenblatt
PATH UiPath
$54.45 /

+1.755 (+3.33%)

09/17/21 Barclays
UiPath upgraded to Overweight from Equal Weight at Barclays
09/08/21 BMO Capital
UiPath price target lowered to $70 from $85 at BMO Capital
09/08/21 Cowen
UiPath price target lowered to $80 from $84 at Cowen
09/08/21 Canaccord
UiPath price target lowered to $65 from $75 at Canaccord
PATH UiPath
$54.45 /

+1.755 (+3.33%)

AYX Alteryx
$75.41 /

-0.07 (-0.09%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
AYX Alteryx
$75.41 /

-0.07 (-0.09%)

PATH UiPath
$54.45 /

+1.755 (+3.33%)

AYX Alteryx
$75.41 /

-0.07 (-0.09%)

PATH UiPath
$54.45 /

+1.755 (+3.33%)

AYX Alteryx
$75.41 /

-0.07 (-0.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.